logo

Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents (including a review of guidance TA13)

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Author
National Institute for Health and Clinical Excellence
Title
Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents (including a review of guidance TA13)
Year
2000
Location
London
Full Item
Read Full Item (New Window)
Publisher(s)
National Institute for Health and Clinical Excellence
Publication Format
Policy Statement
Scientific Validity
Peer-Reviewed, Detailed Description
Keywords
Atomoxetine, Attention Deficit Hyperactivity Disorder, Dextroamphetamine, Intervention, Medication, Methylphenidate, Stimulants

If you know of any other publications we should list on this page please email info@informationautism.org

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Related Interventions


Publications | Publications Database | Search Publications